Its active ingredient is orforglipron, an oral GLP-1 receptor agonist - but unlike semaglutide or tirzepatide, it's a non-peptide small molecule.
That's the mechanism behind its flexibility: it survives digestion without needing an absorption enhancer, so there's no empty-stomach rule and food doesn't meaningfully affect how much is absorbed.
Like other GLP-1s, it reduces appetite via brain receptors, increases satiety by slowing gastric emptying, and helps stabilise blood sugar through increased insulin release and reduced glucagon.